Issue: No measurable vision improvement after 3 months Potential causes: Unrealistic expectations (expecting improvement vs slowed decline), advanced disease with minimal salvageable tissue, inadequate dosing or inconsistent use, wrong peptide for specific condition, peptides genuinely ineffective for individual, progression monitoring inadequate missing subtle benefits
View on PubMed Contributions by the Brain Renin-Angiotensin System to Memory, Cognition, and Alzheimer's Disease Reviewed the role of brain angiotensin signalling in learning, memory, and neurodegeneration, providing mechanistic context for angiotensin IV analog therapies including Dihexa (J Alzheimers Dis, 2019)
Oral administration significantly reduces bioavailability due to enzymatic degradation in the digestive tract
The peptide is typically administered as a subcutaneous injection and can be delivered in-office or as part of our concierge home service in Beverly Hills, Los Angeles, and surrounding areas